Keywords: ligand, trials, targretin, phase, ii, breast, cancer

Ligand Trials Targretin in Phase II Breast Cancer

Article | 09 December 1998

Print This

Ligand Pharmaceuticals has started a Phase II trial with Targretincapsules (bexarotene) in up to 180 patients with advanced breast cancer.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in